OC
ISEE

Oppenheimer & Co’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Oppenheimer & Co’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,633
Closed -$238K – 1311
2016
Q1 		$238K Sell
5,633
-1,794
-24% -$91.4K 0.01% 1035
2015
Q4 		$583K Sell
7,427
-8,650
-54% -$500K 0.02% 722
2015
Q3 		$652K Sell
16,077
-19,578
-55% -$1.04M 0.02% 718
2015
Q2 		$1.86M Buy
35,655
+287
+0.8% +$14.3K 0.05% 422
2015
Q1 		$1.65M Buy
35,368
+14,743
+71% +$765K 0.04% 473
2014
Q4 		$926K Buy
20,625
+2,387
+13% +$100K 0.03% 628
2014
Q3 		$710K Buy
+18,238
New +$716K 0.02% 720

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oppenheimer & Co's ISEE Position: Q2 2016 in Review

Oppenheimer & Co sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2016, closing a stake of 5,633 shares — an estimated $238K sold.

Oppenheimer & Co first reported a position in ISEE in Q3 2014 and held it in 7 quarters. The position peaked at $1.86M in Q2 2015. 182 funds tracked by Wall St. Rank hold ISEE as of Q2 2016.

  • Oppenheimer & Co reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Oppenheimer & Co sold 5,633 IVERIC bio, Inc. Common Stock shares in Q2 2016, an estimated $238K.
  • Oppenheimer & Co first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 7 quarters.
  • Oppenheimer & Co's IVERIC bio, Inc. Common Stock position peaked at $1.86M in Q2 2015.
  • 182 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2016.

Based on Oppenheimer & Co's 13F filing for Q2 2016, filed 8 Aug 2016.